Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk.

Thorpe PG, Gilboa SM, Hernandez-Diaz S, Lind J, Cragan JD, Briggs G, Kweder S, Friedman JM, Mitchell AA, Honein MA; National Birth Defects Prevention Study.

Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):1013-8. doi: 10.1002/pds.3495. Epub 2013 Jul 29.

2.

Drug shortages: the cycle of quantity and quality.

Kweder SL, Dill S.

Clin Pharmacol Ther. 2013 Mar;93(3):245-51. doi: 10.1038/clpt.2012.235. Epub 2012 Dec 6.

PMID:
23340474
3.

Managing multiple chronic conditions: a strategic framework for improving health outcomes and quality of life.

Parekh AK, Goodman RA, Gordon C, Koh HK; HHS Interagency Workgroup on Multiple Chronic Conditions.

Public Health Rep. 2011 Jul-Aug;126(4):460-71.

4.

Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.

Kweder SL.

Birth Defects Res A Clin Mol Teratol. 2008 Sep;82(9):605-9. doi: 10.1002/bdra.20500. No abstract available.

PMID:
18704917
5.

Ketek--the FDA perspective.

Soreth J, Cox E, Kweder S, Jenkins J, Galson S.

N Engl J Med. 2007 Apr 19;356(16):1675-6. No abstract available.

6.

Females in clinical studies: where are we going?

Uhl K, Parekh A, Kweder S.

Clin Pharmacol Ther. 2007 Apr;81(4):600-2. Epub 2007 Feb 21.

PMID:
17314925
7.

Can we ensure the safe use of known human teratogens?: The iPLEDGE test case.

Honein MA, Lindstrom JA, Kweder SL.

Drug Saf. 2007;30(1):5-15. Review.

PMID:
17194167
8.

Pregnancy exposure registries.

Kennedy DL, Uhl K, Kweder SL.

Drug Saf. 2004;27(4):215-28. Review.

PMID:
15003034
9.

Information on medication use in pregnancy.

Uhl K, Kennedy DL, Kweder SL.

Am Fam Physician. 2003 Jun 15;67(12):2476, 2478. No abstract available.

10.

Accurate information on drug effects on pregnancy is crucial.

Uhl K, Kennedy DL, Kweder SL.

Am Fam Physician. 2003 Feb 15;67(4):700-1; author reply 702. No abstract available.

11.
12.

The FDA and The Lancet: an exchange.

Galson S, Kweder S, Houn F, Raczkowski V, Honig PK.

Lancet. 2001 Aug 4;358(9279):415; author reply 417-8. No abstract available.

PMID:
11503619
13.

Teaching internal medicine residents about medical problems in pregnancy.

Powrie R, Kweder S, Rosene-Montella K.

Acad Med. 2000 Feb;75(2):191-3.

PMID:
10693855
14.

Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia.

Weiss RB, Freiman J, Kweder SL, Diehl LF, Byrd JC.

J Clin Oncol. 1998 May;16(5):1885-9.

PMID:
9586905
15.

Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.

Byrd JC, Hertler AA, Weiss RB, Freiman J, Kweder SL, Diehl LF.

Ann Oncol. 1995 Mar;6(3):300-1. No abstract available.

PMID:
7612497
16.

Building a team on a medical floor.

Horak BJ, Guarino JH, Knight CC, Kweder SL.

Health Care Manage Rev. 1991 Spring;16(2):65-71.

PMID:
2055757
17.

Inosine pranobex--is a single positive trial enough?

Kweder SL, Schnur RA, Cooper EC.

N Engl J Med. 1990 Jun 21;322(25):1807-9. No abstract available.

PMID:
1693175

Supplemental Content

Loading ...
Support Center